30 ML eculizumab-aagh 10 MG/ML Injection [Epysqli]
- RxCUI
- 2706345
- RxNorm name
- 30 ML eculizumab-aagh 10 MG/ML Injection [Epysqli]
- Display name
- 30 ML eculizumab-aagh 10 MG/ML Injection [Epysqli]
- Full name
- 30 ML eculizumab-aagh 10 MG/ML Injection [Epysqli]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761340 | Epysqli | eculizumab-aagh | 351(k) Interchangeable | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EPYSQLI | ECULIZUMAB-AAGH | Teva Pharmaceuticals USA, Inc. | 1fa1aa80-1c59-44d4-9841-b6c52882651b | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 2706345 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1fa1aa80-1c59-44d4-9841-b6c52882651b | 30 ML eculizumab-aagh 10 MG/ML Injection [Epysqli] | SBD | 4 | These highlights do not include all the information needed to use EPYSQLI safely and effectively. See full prescribing information for EPYSQLI. EPYSQLI ® (eculizumab-aagh) injection, for intravenous use Initial U.S. Approval: 2024 EPYSQLI (eculizumab-aagh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe | 20260415 |
| 1fa1aa80-1c59-44d4-9841-b6c52882651b | Epysqli 300 MG per 30 ML Injection | SY | 4 | These highlights do not include all the information needed to use EPYSQLI safely and effectively. See full prescribing information for EPYSQLI. EPYSQLI ® (eculizumab-aagh) injection, for intravenous use Initial U.S. Approval: 2024 EPYSQLI (eculizumab-aagh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe | 20260415 |
| 1fa1aa80-1c59-44d4-9841-b6c52882651b | Epysqli 300 MG in 30 ML Injection | PSN | 4 | These highlights do not include all the information needed to use EPYSQLI safely and effectively. See full prescribing information for EPYSQLI. EPYSQLI ® (eculizumab-aagh) injection, for intravenous use Initial U.S. Approval: 2024 EPYSQLI (eculizumab-aagh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe | 20260415 |